BUSE vs. PFE

Last updated Apr 2, 2026

Compare and contrast key facts about First Busey Corporation (BUSE) and Pfizer Inc. (PFE).

Performance

BUSE vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Busey Corporation (BUSE) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

BUSE vs. PFE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BUSE First Busey Corporation	8.20%	5.54%	-1.21%	5.06%	-5.49%	30.66%	-17.89%	15.79%	-15.89%	-0.36%
PFE Pfizer Inc.	16.58%	0.65%	-2.22%	-41.26%	-10.41%	66.70%	3.07%	-6.91%	24.82%	15.90%

Fundamentals

Market Cap BUSE : $2.27B PFE : $162.34B
EPS BUSE : $1.69 PFE : $1.36
PE Ratio BUSE : 15.12 PFE : 20.95
PS Ratio BUSE : 1.96 PFE : 2.60
PB Ratio BUSE : 0.92 PFE : 1.74
Total Revenue (TTM) BUSE : $1.04B PFE : $62.58B
Gross Profit (TTM) BUSE : $669.98M PFE : $44.01B
EBITDA (TTM) BUSE : $208.81M PFE : $15.10B

Returns By Period

In the year-to-date period, BUSE achieves a 8.20% return, which is significantly lower than PFE's 16.58% return. Over the past 10 years, BUSE has outperformed PFE with an annualized return of 6.04%, while PFE has yielded a comparatively lower 4.49% annualized return.

BUSE

• 1D: 0.83%
• 1M: -0.78%
• YTD: 8.20%
• 6M: 12.74%
• 1Y: 23.43%
• 3Y*: 12.56%
• 5Y*: 3.90%
• 10Y*: 6.04%

PFE

• 1D: 1.67%
• 1M: 4.73%
• YTD: 16.58%
• 6M: 8.56%
• 1Y: 24.79%
• 3Y*: -5.70%
• 5Y*: 0.19%
• 10Y*: 4.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BUSE vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BUSE

BUSE Risk / Return Rank: 68
BUSE Sharpe Ratio Rank: 70
BUSE Sortino Ratio Rank: 63
BUSE Omega Ratio Rank: 61
BUSE Calmar Ratio Rank: 76
BUSE Martin Ratio Rank: 72

PFE

PFE Risk / Return Rank: 69
PFE Sharpe Ratio Rank: 72
PFE Sortino Ratio Rank: 66
PFE Omega Ratio Rank: 63
PFE Calmar Ratio Rank: 72
PFE Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BUSE vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Busey Corporation (BUSE) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BUSE	PFE	Difference
Sharpe ratio Return per unit of total volatility	0.87	0.94	-0.07
Sortino ratio Return per unit of downside risk	1.35	1.46	-0.12
Omega ratio Gain probability vs. loss probability	1.17	1.18	-0.01
Calmar ratio Return relative to maximum drawdown	1.97	1.66	+0.31
Martin ratio Return relative to average drawdown	4.18	3.73	+0.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BUSE vs. PFE - Sharpe Ratio Comparison

The current BUSE Sharpe Ratio is 0.87, which is comparable to the PFE Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of BUSE and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BUSE	PFE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.87	0.94	-0.07
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.01	+0.13
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.19	0.19	0.00
Sharpe Ratio (All Time) Calculated using the full available price history	0.05	0.27	-0.22

Correlation

The correlation between BUSE and PFE is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BUSE vs. PFE - Dividend Comparison

BUSE's dividend yield for the trailing twelve months is around 3.96%, less than PFE's 6.02% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BUSE First Busey Corporation	3.96%	4.20%	4.07%	3.87%	3.72%	3.39%	4.08%	3.05%	3.26%	2.40%	2.21%	3.01%
PFE Pfizer Inc.	6.02%	6.91%	6.33%	5.70%	3.12%	2.64%	3.92%	3.68%	3.12%	3.53%	3.69%	3.47%

Drawdowns

BUSE vs. PFE - Drawdown Comparison

The maximum BUSE drawdown since its inception was -85.41%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BUSE and PFE.

Drawdown Indicators

	BUSE	PFE	Difference
Max Drawdown Largest peak-to-trough decline	-85.41%	-58.96%	-26.45%
Max Drawdown (1Y) Largest decline over 1 year	-11.82%	-12.59%	+0.77%
Max Drawdown (5Y) Largest decline over 5 years	-39.24%	-58.96%	+19.72%
Max Drawdown (10Y) Largest decline over 10 years	-54.93%	-58.96%	+4.03%
Current Drawdown Current decline from peak	-28.60%	-41.79%	+13.19%
Average Drawdown Average peak-to-trough decline	-38.36%	-17.33%	-21.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.56%	5.58%	-0.02%

Volatility

BUSE vs. PFE - Volatility Comparison

The current volatility for First Busey Corporation (BUSE) is 5.65%, while Pfizer Inc. (PFE) has a volatility of 6.30%. This indicates that BUSE experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BUSE	PFE	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.65%	6.30%	-0.65%
Volatility (6M) Calculated over the trailing 6-month period	18.27%	17.39%	+0.88%
Volatility (1Y) Calculated over the trailing 1-year period	27.16%	26.78%	+0.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.49%	25.47%	+3.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.51%	23.90%	+7.61%

Financials

BUSE vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between First Busey Corporation and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BUSE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, First Busey Corporation reported a gross profit of 197.81M and revenue of 277.79M. Therefore, the gross margin over that period was 71.2%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.

BUSE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, First Busey Corporation reported an operating income of 77.49M and revenue of 277.79M, resulting in an operating margin of 27.9%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.

BUSE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, First Busey Corporation reported a net income of 60.75M and revenue of 277.79M, resulting in a net margin of 21.9%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.